TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government & Organizations

    Psychopharmacology and Psychiatry Updates

    Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

    Advertise
    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Beyond Black Box Warnings: Choosing Antipsychotics in Dementia Oct 08, 2025
    Show notes

    In this episode, we explore a compelling comparison between olanzapine and risperidone for managing behavioral symptoms in dementia patients. Are the delusions we see in Alzheimer's disease actually true delusions, or something entirely different that requires a new treatment approach?

    Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.75 CME: Quick Take Vol. 73
    • Alzheimer's Disease: Olanzapine vs. Risperidone for BPSD

    SSRIs and Psychedelics: Drug Interactions Oct 03, 2025
    Show notes

    In this episode, we explore the complex drug-drug interactions between psychedelics and psychiatric medications. Do SSRIs really blunt psychedelic effects, or is this just clinical folklore? We'll examine surprising new research and discuss potentially dangerous combinations every psychiatrist should know.

    Faculty: Franklin King, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 1.25 CME: Use of Psychedelic Drugs in Psychiatry
    • Examining the Combined Use of Psychedelics and Psychiatric Drugs

    Standard vs. High Doses: Rethinking Bipolar Maintenance Treatment Sep 28, 2025
    Show notes

    In this episode, we challenge the conventional wisdom of "what gets them well keeps them well" by exploring groundbreaking Finnish research on bipolar disorder medication dosing. Does maintaining patients on high doses actually improve long-term outcomes, or could standard doses be the optimal strategy for relapse prevention?

    Faculty: Kristin Raj, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: Quick Take Vol. 73
    • Bipolar Disorder Maintenance: What's the Optimal Dose Range?

    Psychedelics and Brain Networks Sep 23, 2025
    Show notes

    In this episode, we explore how psychedelics like psilocybin disrupt the brain's default mode network, creating windows of neuroplasticity that correlate with mystical experiences and therapeutic breakthroughs in treatment-resistant depression, anxiety, and addiction.

    Faculty: Franklin King, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 1.25 CMEs: Use of Psychedelic Drugs in Psychiatry
    • How Psychedelics Influence Brain Networks

    LAIs vs Oral Antipsychotics: Mortality Data and Clinical Impact Sep 18, 2025
    Show notes

    In this episode, we explore groundbreaking research showing how long-acting injectable antipsychotics can literally save lives in schizophrenia treatment. Could choosing the right medication delivery method be the difference between a patient thriving or facing premature death by 15-20 years?

    Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: Quick Take Vol. 73
    • Long-Acting Injectables: Superior for Reducing Mortality in Schizophrenia?

    The Science Behind Psychedelic Therapy Sep 13, 2025
    Show notes

    In this episode, we explore the fascinating mechanisms behind psychedelic drugs in psychiatry, examining how substances like psilocybin and LSD work through 5-HT2A receptors to promote neuroplasticity. What if these compounds are hijacking an ancient stress response system designed to help us rapidly adapt to survive?

    Faculty: Franklin King, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 1.25 CME: Use of Psychedelic Drugs in Psychiatry
    • The Mechanisms and Effects of Psychedelics

    Which Antidepressant Causes the Most Weight Gain? Sep 08, 2025
    Show notes

    In this episode, we explore groundbreaking research comparing weight gain across eight common antidepressants. Using data from 183,000 patients, this study finally provides concrete numbers to answer the question patients ask most: How much weight will I gain on this medication?

    Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.5 CME: Quick Take Vol. 72
    • Which Antidepressants Cause the Most Weight Gain?

    Lisdexamfetamine for Binge Eating Disorder Sep 03, 2025
    Show notes

    In this episode, we explore lisdexamfetamine as the first FDA-approved medication for binge eating disorder. Can one medication effectively treat both ADHD and binge eating simultaneously? We examine the evidence, duration of treatment, and strategies for addressing patient ambivalence in eating disorder pharmacotherapy.

    Faculty: Scott Crow, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: Pharmacotherapy of Eating Disorders: An Update
    • Binge Eating Disorder Pharmacotherapy: Lisdexamfetamine

    Beyond Weight Loss: GLP-1 Agonists and Alcohol Use Disorder Aug 29, 2025
    Show notes

    In this episode, we explore groundbreaking Swedish research on GLP-1 receptor agonists as a potential new treatment for alcohol use disorder. Could diabetes medications like semaglutide revolutionize addiction treatment where traditional therapies have fallen short?

    Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.5 CME: Quick Take Vol. 72
    • Which Antidepressants Cause the Most Weight Gain?

    Antidepressants vs. Anticonvulsants for Binge Eating Aug 24, 2025
    Show notes

    In this episode, we explore pharmacotherapy for binge eating disorder, examining how antidepressants, anticonvulsants, and emerging treatments target different patient goals. Should your treatment focus on stopping binge episodes or achieving weight loss? We discuss evidence-based approaches to align medication choices with patient priorities for optimal outcomes.

    Faculty: Scott Crow, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: Pharmacotherapy of Eating Disorders: An Update
    • Binge Eating Disorder Pharmacotherapy: Antidepressants and Anticonvulsants

    Previous 1 7 8 9 10 11 12 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    More Perfect

    2

    More Perfect Government
    Casefile True Crime

    3

    Casefile True Crime Games & Hobbies
    Reply All

    4

    Reply All Games & Hobbies
    You Must Remember This

    5

    You Must Remember This Games & Hobbies
    Real Time with Bill Maher

    6

    Real Time with Bill Maher Games & Hobbies
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights